News & Updates

Despite the uptick in digital cardiology care during the coronavirus disease 2019 (COVID-19) pandemic, several key barriers to wearable device use remain, including high costs and limited technology knowledge, according to a recent study.

For Crohn’s disease patients, achieving a complete and sustained clinical remission off steroids does not necessarily translate to a lower likelihood of experiencing progression, according to data from the TAILORIX trial.

A recent study indicates that treatment of insomnia with cognitive behavioral therapy for insomnia (CBT-I) has an overall benefit in the prevention of incident and recurrent major depression in older adults with insomnia disorder compared with sleep education therapy (SET).

Postoperative treatment with the oral factor XIa inhibitor milvexian could help prevent the incidence of venous thromboembolism (VTE) in patients undergoing elective knee arthroplasty, according to results of a phase II trial presented at AHA 2021.

In a pooled post hoc analysis of three phase III trials, a novel two-dose hepatitis B (hep-B) vaccine regimen trumped the traditional three-dose regimen in inducing seroprotection in patients with chronic liver disease (CLD).